About medicine names
Clinical suffixes do the heavy lifting in results like "Compacine" and "Paropan", while two-part entries such as "Avatensin Zicoxone" mimic the generic-plus-compound format on real prescription labels. The syllables borrow from actual pharmacology, so they pass the squint test on a chart or a label. Use them for sci-fi medbays, satirical drug ads, or the pill bottle a detective finds in act one.
How medicine names are built
Names are built by fusing two affix banks with no space, joining a 530-entry stem to a 336-entry clinical suffix to make one drug word. A two-part template runs that fusion twice to mimic a generic-name-plus-compound label. Because the join is seamless, each half reads as a single invented pharmaceutical. Bank outputs include Janecloral, Sarusunel, and Pariludine Brnecloryl.
Brlolune Paritoral
Brlo (stem) + lune (suffix) + Pari (stem) + toral (suffix)
Pariludine Brnecloryl
Pari (stem) + ludine (suffix) + Brne (stem) + cloryl (suffix)
Launtune Quloloral
Laun (stem) + tune (suffix) + Qulo (stem) + loral (suffix)
Naming notes
The realism comes from the suffix bank: clinical tails like -oral, -oryl, -udine, -onel carry the pharmacological weight, so a plain stem plus a recognised ending reads as a real generic name. The doubled template imitates the way prescription labels pair two compound names, which is why outputs like Pariludine Brnecloryl feel like a fictional script. Keep these as invented drug names for techno-thrillers and medical fiction; the stems and suffixes are tuned for sound, not for any real drug class.
Questions about medicine names
- How is a medicine name generated?
- A stem from a 530-entry bank is fused directly to a clinical suffix from a 336-entry bank, as in Jane + cloral, optionally doubled into a two-part label.
- Why do they sound like real prescriptions?
- The suffix bank carries pharmacological endings such as -oral, -udine, and -oryl, so a stem plus one of these reads like a genuine generic drug name.
- What does the two-part template do?
- It runs the stem-plus-suffix fusion twice, as in Pariludine Brnecloryl, imitating how a label pairs a generic name with a compound name.